X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (106) 106
humans (105) 105
female (84) 84
oncology (67) 67
breast cancer (60) 60
middle aged (50) 50
breast neoplasms - pathology (42) 42
breast neoplasms - genetics (37) 37
cancer (37) 37
aged (35) 35
prognosis (35) 35
adult (34) 34
immunohistochemistry (30) 30
chemotherapy (25) 25
breast neoplasms - drug therapy (23) 23
expression (23) 23
tumors (23) 23
gene expression (18) 18
predictive value of tests (18) 18
treatment outcome (18) 18
breast neoplasms - metabolism (17) 17
aged, 80 and over (16) 16
pathology (16) 16
survival (16) 16
research (15) 15
biomarkers, tumor - analysis (14) 14
receptors, estrogen - analysis (14) 14
research article (14) 14
analysis (13) 13
biopsy (13) 13
lymphocytes (13) 13
mutation (13) 13
antineoplastic agents - therapeutic use (12) 12
breast neoplasms - mortality (12) 12
disease-free survival (12) 12
male (12) 12
metastasis (12) 12
retrospective studies (12) 12
surgery (12) 12
abridged index medicus (11) 11
biomarkers (11) 11
breast (11) 11
genetic aspects (11) 11
receptor, erbb-2 - analysis (11) 11
breast neoplasms - chemistry (10) 10
carcinoma (10) 10
cells (10) 10
gene amplification (10) 10
neoplasms (10) 10
patients (10) 10
risk factors (10) 10
survival analysis (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
care and treatment (9) 9
cell biology (9) 9
cell proliferation (9) 9
identification (9) 9
in situ hybridization, fluorescence (9) 9
trastuzumab (9) 9
adjuvant chemotherapy (8) 8
biomarkers, tumor - genetics (8) 8
breast neoplasms - diagnosis (8) 8
carcinomas (8) 8
erbb-2 protein (8) 8
gene expression regulation, neoplastic (8) 8
health aspects (8) 8
her2 (8) 8
immunology (8) 8
medical prognosis (8) 8
medicine (8) 8
medicine & public health (8) 8
oligonucleotide array sequence analysis (8) 8
phenotype (8) 8
receptors, estrogen - metabolism (8) 8
therapy (8) 8
time factors (8) 8
transcriptome (8) 8
women (8) 8
adjuvant treatment (7) 7
cancer therapies (7) 7
cell line, tumor (7) 7
chemotherapy, adjuvant (7) 7
cohort studies (7) 7
dna topoisomerases, type ii - genetics (7) 7
epirubicin (7) 7
genes (7) 7
genomics (7) 7
hematology, oncology and palliative medicine (7) 7
lymphatic metastasis (7) 7
medicine, research & experimental (7) 7
multivariate analysis (7) 7
receptor, erbb-2 - genetics (7) 7
receptor, erbb-2 - metabolism (7) 7
skin and connective tissue diseases (7) 7
tertiary lymphoid structures (7) 7
trial (7) 7
tumor cells, cultured (7) 7
animals (6) 6
association (6) 6
base sequence (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1134 - 1142
Journal Article
Nature Medicine, ISSN 1078-8956, 07/2015, Volume 21, Issue 7, pp. 751 - 759
Journal Article
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 02/2006, Volume 98, Issue 4, pp. 262 - 272
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2010, Volume 107, Issue 22, pp. 10208 - 10213
PIK3CA mutations are reported to be present in approximately 25% of breast cancer (BC), particularly the estrogen receptor—positive (ER+) and... 
Datasets | Health outcomes | Prognosis | Cell lines | Breast cancer | Signatures | Gene expression | Genetic mutation | Tumors | Cancer | Gene expression profiling | PI3 kinase | MOLECULAR SUBTYPES | TYROSINE PHOSPHORYLATION | MULTIDISCIPLINARY SCIENCES | PTEN | 3-KINASE MUTATIONS | AKT | EXPRESSION PROFILES | TUMORS | INSULIN-RECEPTOR | PATHWAY | POOR-PROGNOSIS | gene expression profiling | Neoplasms, Hormone-Dependent - metabolism | Receptors, Estrogen - metabolism | Oligonucleotide Array Sequence Analysis | Humans | Multiprotein Complexes | Receptor, ErbB-2 - metabolism | DNA Primers - genetics | Gene Expression Profiling | Proto-Oncogene Proteins c-akt - genetics | Breast Neoplasms - metabolism | Mechanistic Target of Rapamycin Complex 1 | Neoplasms, Hormone-Dependent - genetics | Proteins | Antineoplastic Agents, Hormonal - therapeutic use | Base Sequence | Female | Sirolimus - therapeutic use | Signal Transduction | Breast Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Transcription Factors - metabolism | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Antibiotics, Antineoplastic - therapeutic use | Tamoxifen - therapeutic use | Cell Line, Tumor | TOR Serine-Threonine Kinases | Mutation | Neoplasms, Hormone-Dependent - drug therapy | Receptors | Analysis | Estrogen | Genetic aspects | Research | Properties | Tamoxifen | Protein kinases | Health aspects | Genotype & phenotype | Oncology | Kinases | Clinical outcomes | Index Medicus | TOR protein | Transformation | Exons | Estrogens | AKT protein | Data processing | 1-Phosphatidylinositol 3-kinase | Signal transduction | Biological Sciences
Journal Article
Journal Article
Cell Reports, ISSN 2211-1247, 10/2015, Volume 13, Issue 2, pp. 277 - 289
Little is known about how RNA editing operates in cancer. Transcriptome analysis of 68 normal and cancerous breast tissues revealed that the editing enzyme... 
MUTATIONAL PROCESSES | WIDESPREAD RNA | SEQ DATA | ADENOSINE-DEAMINASE | ADAR DEAMINASES | GENE | PARALLEL DNA | SQUAMOUS-CELL CARCINOMA | SITES | IDENTIFICATION | CELL BIOLOGY | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 1, pp. e15624 - e15624
Journal Article